Streetbeat News

Stock Prices

ALT

BHVN

Altimmune Inc (NASDAQ:ALT) reported study results for obesity drug pemvidutide, showing 25.5% of weight loss from lean mass and 74.5% from adipose tissue. The company will present full data at an upcoming meeting. Despite Kerrisdale Capital's skepticism and competition from Biohaven (NASDAQ:BHVN), ALT shares rose 7.51% in premarket trading. Altimmune missed Q4 2023 EPS estimates and reported $198.0 million in cash and equivalents as of December 31, 2023.

Portfolio Pulse from Vandana Singh

March 27, 2024 | 1:31 pm

WMB

Williams Companies Inc. (NYSE:WMB) stock rose 1.58% to $38.69 in the current session, marking a 9.73% increase over the past month and a 31.55% increase over the past year. The company's P/E ratio is lower than the Oil, Gas & Consumable Fuels industry average, suggesting it might be undervalued despite its strong performance.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 1:30 pm

MRDB

PRGS

MariaDB plc (NYSE:MRDB) shares surged after Progress Software Corporation (NASDAQ:PRGS) proposed to acquire all issued share capital of MariaDB at $0.60 per share, an 88% premium over the last 30 trading days' average and a 216% premium over the closing price on February 5, 2024. The offer also exceeds a previous $0.55 per share offer from K1 Capital. Progress is ready to engage with MariaDB's Board to expedite the offer. As of February 29, 2024, Progress Software had $133.2 million in cash and equivalents.

Portfolio Pulse from Lekha Gupta

March 27, 2024 | 1:28 pm

RUN

Sunrun Inc (NASDAQ:RUN) shares are trading higher after being selected to move from the S&P MidCap 400 to the S&P SmallCap 600, replacing PGT Innovations. This change is effective prior to market open on April 1, as MITER Brands acquires PGT Innovations. Sunrun's stock has been declining, with a more than 40% drop over a year and a -2.65% revenue growth in FY23. The company's performance is influenced by macroeconomic factors such as interest rates, inflation, and labor market strength.

Portfolio Pulse from Adam Eckert

March 27, 2024 | 1:28 pm

OPGN

OpGen shares are trading lower following a significant surge on Tuesday, indicating a pullback in the stock's recent gains.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:26 pm

NTRB

Nutriband shares surged following the company's announcement of a clinical and regulatory path overview for its AVERSA Fentanyl patch.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:25 pm

AURA

Aura Biosciences (NASDAQ:AURA) reported Q4 earnings, beating estimates with an EPS of $-0.5 against an expected $-1.82 but with no change in revenue from the previous year. The company had previously seen a 10% share price increase following last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 1:25 pm

LUXH

LuxUrban shares are trading lower following the company's announcement of a preliminary Q4 revenue outlook that fell below estimates.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:24 pm

ACM

GTLS

HII

STT

V

Jim Cramer discussed various companies on CNBC's 'Mad Money Lightning Round,' praising Visa Inc. (V) and Chart Industries (GTLS), while expressing caution about State Street Corporation (STT) and AECOM (ACM) due to their current stock prices. Visa and Mastercard Incorporated (MA) reached a significant antitrust settlement, and Cramer showed preference for Wells Fargo & Company (WFC) and Morgan Stanley (MS) over STT. He also highlighted Huntington Ingalls Industries (HII) as a strong navy contractor.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 1:24 pm

LIXT

LIXTE shares surged following the announcement of positive pre-clinical data on its lead clinical compound, LB-100.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 1:24 pm